TransCode Therapeutics (RNAZ) Financial Statements

439 Followers

TransCode Therapeutics Financial Overview

TransCode Therapeutics's market cap is currently $7.81M. The company's EPS TTM is $; its P/E ratio is -0.14; TransCode Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Mar 24	Dec 22	Mar 22
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -534.86K	$ -516.75K	$ -98.61K	$ -42.47K
Operating Income	$ -27.98M	$ -15.66M	$ -19.42M	$ -18.67M	$ -6.15M
EBITDA	$ -34.31M	$ -16.19M	$ -17.97M	$ -17.47M	$ -6.71M
Net Income	$ -34.66M	$ -16.75M	$ -18.55M	$ -17.56M	$ -6.84M
Balance Sheet
Cash & Short-Term Investments	$ 17.81B	$ 5.81M	$ 2.77M	$ 4.98M	$ 20.83M
Total Assets	$ 162.40M	$ 7.29M	$ 5.17M	$ 7.59M	$ 22.94M
Total Debt	$ 0.00	$ 38.29K	$ 450.57K	$ 0.00	$ 0.00
Net Debt	$ -17.81B	$ -5.77M	$ -2.32M	$ -4.97M	$ -20.83M
Total Liabilities	$ 10.52B	$ 9.31M	$ 3.53M	$ 4.35M	$ 2.53M
Stockholders' Equity	$ 151.88M	$ -2.02M	$ 1.64M	$ 3.24M	$ 20.40M
Cash Flow
Free Cash Flow	$ -19.52M	$ -13.36M	$ -18.11M	$ -15.86M	$ -5.52M
Operating Cash Flow	$ -19.52M	$ -13.34M	$ -18.07M	$ -15.76M	$ -5.27M
Investing Cash Flow	$ -4.44K	$ -21.76K	$ -35.61K	$ -100.92K	$ -251.82K
Financing Cash Flow	$ 31.52M	$ 16.40M	$ 15.91M	$ 5.99K	$ 25.52M

Currency in USD

TransCode Therapeutics Earnings and Revenue History

Income Statement >

TransCode Therapeutics Debt to Assets

Balance Sheet >

TransCode Therapeutics Cash Flow

Cash Flow >

TransCode Therapeutics Forecast EPS vs Actual EPS

Earnings >